Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 April 2019 | Story Valentino Ndaba | Photo Charl Devenish
LJ van Zyl
“May the best team win the 2019 BestMed Pedometer Challenge!” said LJ van Zyl, Pedometer Challenge ambassador.

Participants in the 2019 BestMed Pedometer Challenge will start improving their health step by step after the University of the Free State (UFS) challenged the Stellenbosch University, Central University of Technology, and North-West University (NWU) to an eight-week walking competition.

South African 400-metre hurdles record-holder and the Pedometer Challenge ambassador, LJ van Zyl, embraced the initiative as an alternative method to achieve fitness. “I am so tired of running and this is great way to stay fit,” he said during the official launch on the UFS Bloemfontein Campus on 5 April 2019.

Inter-institutional fight for fitness

Last year, the UFS Division for Organisational Development and Employment Wellness in the Department of Human Resources led a UFS-only challenge that saw 60 teams of staff members log a total of 54 606 km in eight weeks. The division then challenged the NWU.

Together, the NWU and UFS walked 132 000 km. This year, the UFS is taking it one step further by challenging two more institutions.
  
Leading the way

“We aim to get South Africa active – starting with the UFS – by embracing fitness and health ourselves,” said Arina Engelbrecht, UFS Employee Wellness Specialist.

Participants on all fitness and activity levels will gun for a 200 000 km target over 10 weeks.

The challenge kicked off on the Bloemfontein Campus with a 3-km walk at the launch, leaving 199 997 km between the four universities for the rest of the eight-week challenge.

News Archive

Death may come in adorable little packages
2015-03-23

The main host of the Lassa virus is the Natal Mulimammate mouse.

Photo: Supplied

Postdoctoral researcher, Abdon Atangana, of the Institute for Groundwater Studies at the university recently published an article online about the Lassa Haemorrhagic fever in the Natural Computing Applications Forum. In addition to the terminal transmissible sickness recognised as Ebola haemorrhagic fever, there is another strain called Lassa haemorrhagic fever.

The disease is classified under the arenaviridae virus family. The first outbreaks of the disease were observed in Nigeria, Liberia, Sierra Leone, and the Central African Republic. However, it was first described in 1969 in the town of Lassa, in Borno State, Nigeria.

The main host of the Lassa virus is the Natal Mulimammate mouse, an animal indigenous to most of Sub-Saharan Africa. The contamination in humans characteristically takes place through exposure to animal excrement through the respiratory or gastrointestinal tracts.

Mouthfuls of air containing tiny particle of infective material are understood to be the most noteworthy way of exposure. It is also possible to acquire the infection through broken skin or mucous membranes that are directly exposed to the infective material.

“The aim of my research was to propose a novel mathematical equation used to describe the spread of the illness amongst pregnant women in West Africa. To achieve this, I used my newly-proposed derivative with fractional order called beta-derivative. Since none of the commonly used integral transform could be used to derive the solution of the proposed model, I proposed a new integral transform called Atangana-Transform, and used it, together with some iterative technique, to derive the solution of the model.

“My numerical simulations show that the disease is as deadly amongst pregnant women as Ebola,” Abdon said.

Abdon’s research was submitted to one of Springer’s top-tier journals with an impact factor 1.78. The paper was accepted and published February 2015.

Read more about Abdon’s research.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept